186 related articles for article (PubMed ID: 24853741)
1. Probing the transmembrane structure and dynamics of microsomal NADPH-cytochrome P450 oxidoreductase by solid-state NMR.
Huang R; Yamamoto K; Zhang M; Popovych N; Hung I; Im SC; Gan Z; Waskell L; Ramamoorthy A
Biophys J; 2014 May; 106(10):2126-33. PubMed ID: 24853741
[TBL] [Abstract][Full Text] [Related]
2. Structural and Functional Studies of the Membrane-Binding Domain of NADPH-Cytochrome P450 Oxidoreductase.
Xia C; Shen AL; Duangkaew P; Kotewong R; Rongnoparut P; Feix J; Kim JP
Biochemistry; 2019 May; 58(19):2408-2418. PubMed ID: 31009206
[TBL] [Abstract][Full Text] [Related]
3. Conformational changes of NADPH-cytochrome P450 oxidoreductase are essential for catalysis and cofactor binding.
Xia C; Hamdane D; Shen AL; Choi V; Kasper CB; Pearl NM; Zhang H; Im SC; Waskell L; Kim JJ
J Biol Chem; 2011 May; 286(18):16246-60. PubMed ID: 21345800
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.
Hamdane D; Xia C; Im SC; Zhang H; Kim JJ; Waskell L
J Biol Chem; 2009 Apr; 284(17):11374-84. PubMed ID: 19171935
[TBL] [Abstract][Full Text] [Related]
5. The FMN "140s Loop" of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450.
Rwere F; Im S; Waskell L
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638963
[TBL] [Abstract][Full Text] [Related]
6. Nanodisc reconstitution of flavin mononucleotide binding domain of cytochrome-P450-reductase enables high-resolution NMR probing.
Krishnarjuna B; Yamazaki T; Anantharamaiah GM; Ramamoorthy A
Chem Commun (Camb); 2021 May; 57(39):4819-4822. PubMed ID: 33982687
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a NADPH-cytochrome P450 oxidoreductase (CYPOR) and heme oxygenase 1 fusion protein implies a conformational change in CYPOR upon NADPH/NADP
Sugishima M; Sato H; Wada K; Yamamoto K
FEBS Lett; 2019 Apr; 593(8):868-875. PubMed ID: 30883732
[TBL] [Abstract][Full Text] [Related]
8. Chimeric enzymes of cytochrome P450 oxidoreductase and neuronal nitric-oxide synthase reductase domain reveal structural and functional differences.
Roman LJ; McLain J; Masters BS
J Biol Chem; 2003 Jul; 278(28):25700-7. PubMed ID: 12730215
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and structural characterization of the interaction between the FMN binding domain of cytochrome P450 reductase and cytochrome c.
Huang R; Zhang M; Rwere F; Waskell L; Ramamoorthy A
J Biol Chem; 2015 Feb; 290(8):4843-4855. PubMed ID: 25512382
[TBL] [Abstract][Full Text] [Related]
10. Mutations of human cytochrome P450 reductase differentially modulate heme oxygenase-1 activity and oligomerization.
Marohnic CC; Huber Iii WJ; Patrick Connick J; Reed JR; McCammon K; Panda SP; Martásek P; Backes WL; Masters BS
Arch Biochem Biophys; 2011 Sep; 513(1):42-50. PubMed ID: 21741353
[TBL] [Abstract][Full Text] [Related]
11. NADPH-cytochrome P450 oxidoreductase: prototypic member of the diflavin reductase family.
Iyanagi T; Xia C; Kim JJ
Arch Biochem Biophys; 2012 Dec; 528(1):72-89. PubMed ID: 22982532
[TBL] [Abstract][Full Text] [Related]
12. Modeling of Anopheles minimus Mosquito NADPH-cytochrome P450 oxidoreductase (CYPOR) and mutagenesis analysis.
Sarapusit S; Lertkiatmongkol P; Duangkaew P; Rongnoparut P
Int J Mol Sci; 2013 Jan; 14(1):1788-801. PubMed ID: 23325047
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase.
Zhang J; Martàsek P; Paschke R; Shea T; Siler Masters BS; Kim JJ
J Biol Chem; 2001 Oct; 276(40):37506-13. PubMed ID: 11473123
[TBL] [Abstract][Full Text] [Related]
14. The closed and compact domain organization of the 70-kDa human cytochrome P450 reductase in its oxidized state as revealed by NMR.
Vincent B; Morellet N; Fatemi F; Aigrain L; Truan G; Guittet E; Lescop E
J Mol Biol; 2012 Jul; 420(4-5):296-309. PubMed ID: 22543241
[TBL] [Abstract][Full Text] [Related]
15. Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone.
Rwere F; Xia C; Im S; Haque MM; Stuehr DJ; Waskell L; Kim JJ
J Biol Chem; 2016 Jul; 291(28):14639-61. PubMed ID: 27189945
[TBL] [Abstract][Full Text] [Related]
16. Human cytochrome P450 oxidoreductase deficiency caused by the Y181D mutation: molecular consequences and rescue of defect.
Marohnic CC; Panda SP; McCammon K; Rueff J; Masters BS; Kranendonk M
Drug Metab Dispos; 2010 Feb; 38(2):332-40. PubMed ID: 19884324
[TBL] [Abstract][Full Text] [Related]
17. Recruitment of governing elements for electron transfer in the nitric oxide synthase family.
Jáchymová M; Martásek P; Panda S; Roman LJ; Panda M; Shea TM; Ishimura Y; Kim JJ; Masters BS
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15833-8. PubMed ID: 16249336
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics simulations give insight into the conformational change, complex formation, and electron transfer pathway for cytochrome P450 reductase.
Sündermann A; Oostenbrink C
Protein Sci; 2013 Sep; 22(9):1183-95. PubMed ID: 23832577
[TBL] [Abstract][Full Text] [Related]
19. 1H, 15N and 13C NMR resonance assignment, secondary structure and global fold of the FMN-binding domain of human cytochrome P450 reductase.
Barsukov I; Modi S; Lian LY; Sze KH; Paine MJ; Wolf CR; Roberts GC
J Biomol NMR; 1997 Jul; 10(1):63-75. PubMed ID: 9335117
[TBL] [Abstract][Full Text] [Related]
20. The cytochromes P450 and b5 and their reductases--promising targets for structural studies by advanced solid-state NMR spectroscopy.
Dürr UH; Waskell L; Ramamoorthy A
Biochim Biophys Acta; 2007 Dec; 1768(12):3235-59. PubMed ID: 17945183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
